登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Additional file 1 of Challenges and new technologies in adoptive cell therapy
Additional file 1 of Challenges and new technologies in adoptive cell therapy
收藏
Figshare
2023-08-18 更新
2026-04-28 收录
癌症免疫治疗
临床试验分析
数据链接：
https://figshare.com/articles/dataset/Additional_file_1_of_Challenges_and_new_technologies_in_adoptive_cell_therapy/24597799
数据链接
链接失效反馈
官方服务：
问题咨询
购买咨询
在线客服
NEW
资源简介：
Additional file 1. Clinical trials of ACTs for cancer
应用场景：
创建时间：
2023-08-18
相关数据集
Chapter 6- Deep Immunoprofiling HBV PD1/PD-L1
癌症免疫治疗
生物标志物
Correlation analysis is partially displayed in chapter 6 of thesis. Includes Spearmans R, 95% CI and P-values
DataCite Commons
2022-07-18 更新
7
0
TMEscore and grouping information of samples used for subsequent analysis.
肿瘤微环境评分
癌症免疫治疗
(XLSX)
NIAID Data Ecosystem
5
0
Proteomics and RNAseq Data.xlsx
癌症免疫治疗
生物信息学
Proteomics and RNAseq Data for "Engineering pyroptotic vesicles as personalized cancer vaccines".
Figshare
2025-05-16 更新
2
0
CD137 costimulation counteracts TGFβ inhibition of NK cell anti-tumor function and promotes the acquisition of tissue-resident Th9-like properties [4 treatments]. CD137 costimulation counteracts TGFβ inhibition of NK cell anti-tumor function and promotes the acquisition of tissue-resident Th9-like properties [4 treatments]
癌症免疫治疗
NK细胞功能
Enhancing NK cell-based cancer immunotherapy by overcoming immunosuppression is an unmet goal. Here, we demonstrate the ability of the anti-CD137 agonist urelumab for overcoming TGF-β-mediated inhibit
NIAID Data Ecosystem
6
0
Proteomics and RNAseq Data.xlsx
癌症免疫治疗
多组学数据
Proteomics and RNAseq Data for "Engineering pyroptotic vesicles as personalized cancer vaccines".
NIAID Data Ecosystem
2
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广
